Acromegaly screening: Difference between revisions
| Line 7: | Line 7: | ||
== Screening == | == Screening == | ||
According to the endocrine society, screening for acromegaly by measurement of [[IGF-1]] is recommended among patients with the clinical features of acromegaly. These features include the following:<ref name="pmid25356808">{{cite journal| author=Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al.| title=Acromegaly: an endocrine society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2014 | volume= 99 | issue= 11 | pages= 3933-51 | pmid=25356808 | doi=10.1210/jc.2014-2700 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25356808 }} </ref> | |||
*Enlarged [[hands]] and [[feet]] | |||
*Change in the [[facial]] features | |||
*[[Headache]] | |||
*Increase [[sweating]] | |||
*[[Paraesthesia]] | |||
*[[Skin]] thickening | |||
*Protrusion of the lower [[jaw]] | |||
Screening also is recommended in patients with associated conditions of acromegaly. Acromegaly is associated with different comorbidities so that screening is important in patients with these comorbidities which include: | |||
*[[Diabetes mellitus|Diabetes Mellitus]] | |||
*[[Carpal tunnel syndrome]] | |||
*[[Arthritis]] | |||
*[[Sleep apnea]] | |||
*[[Hypertension]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 21:38, 24 August 2017
|
Acromegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acromegaly screening On the Web |
|
American Roentgen Ray Society Images of Acromegaly screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
According to the endocrine society, screening for acromegaly is recommended among patients with clinical features of acromegaly. These features include enlarged hands and feet, frontal protrusion, and skin thickening. The screening is performed by measurement of the IGF-1.
Screening
According to the endocrine society, screening for acromegaly by measurement of IGF-1 is recommended among patients with the clinical features of acromegaly. These features include the following:[1]
- Enlarged hands and feet
- Change in the facial features
- Headache
- Increase sweating
- Paraesthesia
- Skin thickening
- Protrusion of the lower jaw
Screening also is recommended in patients with associated conditions of acromegaly. Acromegaly is associated with different comorbidities so that screening is important in patients with these comorbidities which include:
References
- ↑ Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A; et al. (2014). "Acromegaly: an endocrine society clinical practice guideline". J Clin Endocrinol Metab. 99 (11): 3933–51. doi:10.1210/jc.2014-2700. PMID 25356808.